Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, announces that its operating company, Univercells Technologies (“UT”), a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has been acquired by Donaldson Company, Inc. (NYSE: DCI). UT’s single-use bioreactor systems and integrated biomanufacturing platforms, focused on the production of viruses used in cell and gene therapy, viral vaccines and other therapeutics, will add to Donaldson’s growing offering in life sciences.
Read the full article: Univercells Technologies Acquired by Donaldson Company //
Source: https://www.prnewswire.com/news-releases/univercells-technologies-acquired-by-donaldson-company-301867767.html